SCHEMBL31070925

SCHEMBL31070925

CCN(CC)CCc1cc(N)ccc1C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.49
HTR3A P46098 2/20 0.49
HRH3 Q9Y5N1 2/20 0.49
CHRM2 P08172 1/20 0.49
CHRM3 P20309 1/20 0.49
HTR2C P28335 1/20 0.49
CHRNA4 P43681 1/20 0.49
KCNH2 Q12809 1/20 0.49
PRKCI P41743 1/20 0.49
ACHE P22303 2/20 0.47
CYP2D6 P10635 2/20 0.46
CYP1A2 P05177 1/20 0.46
SCN1A P35498 1/20 0.46
SCN2A Q99250 1/20 0.46
SCN3A Q9NY46 1/20 0.46
ALDH1A1 P00352 5/20 0.45
MAPT P10636 3/20 0.45
KDM4E B2RXH2 3/20 0.45
CYP3A4 P08684 2/20 0.45
GAA P10253 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1568843 1.00 MAOA (0.49) MAOAHTR3AHRH3CHRM2CHRM3
Hydrochloric Acid SCHEMBL7238288 0.98 ACHE (0.50) MAOAHTR3AHRH3CHRM2CHRM3
Procaine SCHEMBL174070 0.86 CYP2D6 (0.69) MAOAHTR3AHRH3CHRM2CHRM3
SCHEMBL9128007 0.84 MAPT (0.47) MAOAHTR3AHRH3CHRM2CHRM3
SCHEMBL16039694 0.83 CSNK2A1 (0.42) SCN1ASCN2ASCN3AALDH1A1MAPT
SCHEMBL25282932 0.83 CYP2D6 (0.65) MAOAHTR3AHRH3CHRM2CHRM3
SCHEMBL1931833 0.82 MAPT (0.52) PRKCIACHEALDH1A1MAPTKDM4E
SCHEMBL28062236 0.82 ALDH1A1 (0.59) CYP1A2ALDH1A1MAPTKDM4ECYP3A4
SCHEMBL3325487 0.80 CA2 (0.45) ALDH1A1KDM4ECYP2C19MAPK1TDP1
SCHEMBL182142 0.80 ALDH1A1 (0.57) PRKCIACHEALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118354759-A Compositions comprising 2' -deoxycytidine analogs and their use for treating sickle cell disease, thalassemia and cancer 阿基拉比奥有限公司 2024-07-16 CN disclosed